CASE STUDY OF FIVE PATIENTS SUFFERING DIABETIC FOOT ULCERS WHO WERE TREATED WITH A NOVEL DEBRIDING...
-
Upload
stanley-russell -
Category
Documents
-
view
214 -
download
0
Transcript of CASE STUDY OF FIVE PATIENTS SUFFERING DIABETIC FOOT ULCERS WHO WERE TREATED WITH A NOVEL DEBRIDING...
CASE STUDY OF FIVE PATIENTS SUFFERING DIABETIC FOOT ULCERS WHO WERE TREATED WITH A NOVEL DEBRIDING BROAD SPECTRUM ANTIMICROBIAL WOUND HEALER:
ASSESSMENT ON T.I.M.E. FRAMEWORK
D Helin1 , A Spyckerelle1, V De Corte², F Michels1, J Van Der Bauwhede1,G Vanhaverbeke 1
1 AZ Groeninge, Campus Onze-Lieve-Vrouw, Diabetic foot clinic, Reepkaai 4, 8500 Kortrijk, Belgium² Flen Pharma NV, Blauwesteenstraat 87, Kontich, Belgium
Introduction
Diabetic foot ulcers remain a significant problem in health care with complications accompanying the disorder, which is a major cause of hospitalization. Although standards of care have been proposed, there is as yet no universal agreement about treatment. Care givers are confronted with a decision about which dressing to choose in order to optimally control exudates as well as keep the wound free from infection. The aim of this study was to assess the therapeutic outcome according to the T.I.M.E. concept in patients treated with a novel wound bio-healer (Flaminal®).
Methods
Five patients with diabetic foot ulcers were seen at a day clinic and the cause of the diabetic foot wound was determined. Wound treatment consisted of rinsing the ulcer with isotonic solution (0.9% NaCl) and disinfection with povidone-iodine solution. Flaminal® was applied to the wounds and size, wound bed status, infection state and wound edges were assessed throughout treatment. In patient 1 and 5, relief of pressure on the foot sole was accomplished using a felt.
Assessment within T.I.M.E. framework
Results
Of the five patients, four were suffering from neuropathy and one from angiopathy. Two patients showed complete recovery of the wounds, one within two months and one within three months. For the other three patients, a significant improvement according to the T.I.M.E. concept was established. There was a reduction in risk of infection. Wound exudate, wound edges and surrounding skin were controlled. All patients showed a favourable outcome of treatment within six months.
Conclusion
Our results showed that the new wound bio-healer (Flaminal®) was effective in the treatment of diabetic foot ulcers according to the T.I.M.E. concept.
20/4/200717/7/2007 2/10/2007
T : necrosis on the
small toe
I : inflammation and high
risk of infection
M : no exudate
E : soft
T : amputation of the toe –
fibrine and presence of a
red wound bed
I : high risk of infection
M : few amounts of exudate
E : no maceration
T : granulation tissue clearly
present
I : no infection
M : minimal amounts of
exudate
E : good closure
Wound was healing optimally
Patient information
Table 1 indicates most important parameters of patients. Bold representstreated ulcer in this study.
11/12/2007
8/1/2008
T : red wound of certain
depth
I : inflammation
M : few amounts of exudate
E : maceration
T : upgranulation of
the wound
I : no inflammation
M : few amounts of exudate
E : no maceration
T : granulation tissue
I : no infection
M : minimal exudate
E : epithelial advancement
Clear progression towards complete healing
20/3/2007 15/5/2007 12/6/2007
T : necrosis – fibrine in
wound bed –1,5 cm
width
I : inflammation – high risk
of infection
M : few to moderate
amounts of exudate
E : red wound edges
T : granulation
I : no infection
M : minimal amounts of
exudate
E : healthy wound edges
Wound almost completely healed
13/2/2007 13/3/2007
T : red-yellow wound
bed – wound of
certain depth
I : risk of infection
M : few to moderate
amounts of exudate
E : callus
T : satisfying granulation –
red wound bed
I : no infection
M : few amounts of exudate
E : healthy wound edges
Diameter of the wound reduced by 50%
T : healed
I : no infection
M : healed
E : healed
Complete healing of wound
T : granulation – red wound
bed
I : no infection
M : few amounts of exudate
E : healthy wound edges
Progression towards healing
Wound progression in time
24/4/2007
8/4/2008
24/7/200716/10/2007
T : red wound bed – 2 cm
diameter
I : high risk of infection
M : few amounts of exudate
E : maceration
T : good granulation – red
wound bed – 1,5 cm
diameter
I : no infection
M : few amounts of exudate
E : healthy wound edges
Satisfying progression of the wound healing process
T : good granulation – 0,5
cm diameter
I : no infection
M : minimal amounts of
exudate
E : healthy wound edges
Optimal healing of the wound
27/6/2007
age medical history
patient 1 63 diabetic type 2 since 1990
insuline since 2000
peripheral vascular insufficiency
arterial hypertension
neuropathic ulcer right foot
patient 2 68
insuline since 2006
chronic kidney insufficiency
angiopathic ulcer amputated toe
patient 3 48
neuropathic foot ulcer thick toe
patient 4 73 diabetic type 2 since 2002
kidney insufficiency
macrovascular deficiency lower leg
surgical intervention carotis
transient ischaemic attack
neuropathic ulcer big toe
patient 5 48 diabetic type 2 since 2002
metformin medication
neuropathic ulcer foot sole
diabetic type 2 since 1985
diabetic nephropathy
diabetic type 1
major microangiopathy